These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease. Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907 [TBL] [Abstract][Full Text] [Related]
24. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease. Gorenflo M; Gu H; Xu Z Cardiology; 2010; 116(1):10-7. PubMed ID: 20424447 [TBL] [Abstract][Full Text] [Related]
25. [Effects of inhaled aerosolized iloprost in adult patients with pulmonary arterial hypertension on right heart functions]. Guo XX; Tian Z; Liu YT; Wang Q; Li MT; Zeng XF; Zhu WL; Fang Q Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2832-6. PubMed ID: 22333544 [TBL] [Abstract][Full Text] [Related]
26. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension]. Andreassen AK; Madsen S; Kjekshus J; Simonsen S Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748 [TBL] [Abstract][Full Text] [Related]
27. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery. Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672 [TBL] [Abstract][Full Text] [Related]
29. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Wolff B; Lodziewski S; Bollmann T; Opitz CF; Ewert R Am Heart J; 2007 Jun; 153(6):1088.e1-7. PubMed ID: 17540215 [TBL] [Abstract][Full Text] [Related]
30. [SPECIFICS OF INHALED ILOPROST PHARMACODYNAMICS IN PATIENTS WITH SEVERE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION]. Bautin AE; Iakovlev AS; Tashkhanov DM; Datsenko SV; Marichev AO; Popov MA; Fedotov PA Anesteziol Reanimatol; 2015; 60(2):4-7. PubMed ID: 26148353 [TBL] [Abstract][Full Text] [Related]
31. [Long-term treatment of primary pulmonary hypertension with inhaled iloprost]. Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H Pneumologie; 2001 Jan; 55(1):38-43. PubMed ID: 11236355 [TBL] [Abstract][Full Text] [Related]
32. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension. Girard C; Fargnoli JM; Godin-Ribuot D; Dutheil V; Maitrasse B; Girardet P; Arvieux CC J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786 [TBL] [Abstract][Full Text] [Related]
33. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study. Fattouch K; Sbraga F; Sampognaro R; Bianco G; Gucciardo M; Lavalle C; Vizza CD; Fedele F; Ruvolo G J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):119-23. PubMed ID: 16645371 [TBL] [Abstract][Full Text] [Related]
34. Aerosolized iloprost in CREST syndrome related pulmonary hypertension. Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165 [TBL] [Abstract][Full Text] [Related]
35. [Immediately effects of inhaled aerosolised iloprost in adult patients with severe pulmonary hypertension secondary to congenital heart diseases]. Zhang CJ; Huang YG; Shen JJ; Huang T; Huang WH; Cui YL; Huang XS Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):65-8. PubMed ID: 21418801 [TBL] [Abstract][Full Text] [Related]
36. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Ardehali A; Hughes K; Sadeghi A; Esmailian F; Marelli D; Moriguchi J; Hamilton MA; Kobashigawa J; Laks H Transplantation; 2001 Aug; 72(4):638-41. PubMed ID: 11544423 [TBL] [Abstract][Full Text] [Related]
37. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. Winterhalter M; Simon A; Fischer S; Rahe-Meyer N; Chamtzidou N; Hecker H; Zuk J; Piepenbrock S; Strüber M J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):406-13. PubMed ID: 18503929 [TBL] [Abstract][Full Text] [Related]
38. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension. Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263 [TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance. Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041 [TBL] [Abstract][Full Text] [Related]
40. Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease. Dernaika TA; Beavin M; Kinasewitz GT Respiration; 2010; 79(5):377-82. PubMed ID: 19786728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]